|
|||||
|
|
Prognostic value of pretreatment 18F‐fluorodeoxyglucose positron emission tomography/CT volume‐based parameters in patients with oropharyngeal squamous cell carcinoma with known p16 and p53 status |
|
| Authors: | Shogo Shinohara MD PhD Yu Usami DDS PhD Yukihiro Imai MD PhD Megumu Hino MD PhD Kyo Itoh MD PhD Risa Tona MD Yuji Kanazawa MD Ippei Kishimoto MD Hiroyuki Harada MD Yasushi Naito MD PhD |
| Institution: | 1. Department of Otolaryngology–Head and Neck Surgery, Kobe City Medical Center General Hospital, Kobe City, Japan;2. Department of Clinical Laboratory, Osaka University Dental Hospital, Osaka, Japan;3. Department of Clinical Pathology, Kobe City Medical Center General Hospital, Kobe City, Japan;4. Department of Radiology, Kobe City Medical Center General Hospital, Kobe City, Japan;5. Institute of Biomedical Research and Innovation, Kobe City, Japan |
| Abstract: | |
| Keywords: | oropharyngeal squamous cell carcinoma 18F‐fluorodeoxyglucose (FDG) positron emission tomography (PET)/CT human papillomavirus (HPV) p16 p53 |